Abstract
Migraine is a serious neurological disorder characterised by recurrent
headaches, varying in severity and frequency. Accounting for the loss of over
100 million working days in the US alone, the economic cost and social impact
of migraine is significant. Furthermore, the people most susceptible to
migraine are those within their most productive years (22-55), causing both
personal and professional disruptions and a significant burden on healthcare
services.
This in-depth management report examines the prospects for anti-migraine drugs
from 2007, right through till 2022. It delivers sales forecasts for the
leading pharmaceutical products, so that you can analyse your pipeline and
market. The market for anti-migraine drugs is the slowest growing segments in
the pain management market with a CAGR of 0.11% for the period 2006-2012.
However this slow growth will be due to the 2009 patent expiry of the leading
product in the market.
Nevertheless, visiongain predicts that with a high prevalence of migraine, the
success of newer triptans and the launch of new therapies, the market will
expand further beyond 2012, generating revenues of $5268m in 2022, increasing
CAGR for the period 2006-2022 to 2.7%. This detailed report also highlights
pipeline developments and important contemporary issues, especially commercial
drivers and restraints.
The Anti-Migraine Market 2007 examines the market critically through a
comprehensive review of available information. Sources include industrial
databases, commercial news, published reports, economic research and
consultation with experts. Visiongain applies financial forecasting,
qualitative analyses and the assessment of unmet needs to provide a
comprehensive market report with detailed analysis and informed opinion.
In particular, The Anti-Migraine Market concentrates on the following
essential aspects of the market:
- Discussion of the current pharmaceutical market
- Forecast of the worldwide pharmaceutical market from 2007-2022
- Drivers and restraints facing the anti-migraine market
- Opportunities and threats facing the anti-migraine market
- Growth of the anti-migraine sector between 2007-2022
- Commercial prospects for the market-leading drugs, with sales forecasts
from 2007-2012
- The potential of generics manufacturers to penetrate this market
- Pipeline developments with blockbuster potential
- Currently marketed drugs with blockbuster potential
- Discussion of unmet therapeutic needs and relative advantages of products
Why you should buy this report:
- To receive a comprehensive analysis of the prospects for anti-migraine
drugs from 2007-2012
- To discover predicted revenues, growth rates and other key metrics for
leading pharmaceutical treatments from 2007-2012
- To determine key activities of leading companies
- To discover "hot" pipeline developments and up-and-coming products
- To determine the forces that influence the market for anti-migraine
products:
- Competitive characteristics of the market
- Drivers
- Restraints
- Strengths, weaknesses, opportunities and threats (SWOT analysis)
- To find out where the anti-migraine market is heading - both
technologically and commercially
The report provides in-depth market analysis upon these areas, and extensively
identifies both prescription and OTC drugs. The report also focuses on the
technological issues, including the latest trends, patents, new products and
other influential factors. The study also assesses the challenges faced by
companies in the pain industry, and what exciting market opportunities exist
in this up- and-coming therapeutic area.
Why You Must Buy This Report?
This report features news, insights, the latest developments and an in depth
survey of the pain market with up-to-date analysis as well as tables, graphs
and charts. This report is a vital addition to gaining an understanding of
this market sector and will give your company ' the edge' on your competitors.
You can not afford to be without this latest report from visiongain.
Unique benefits to you when you order this report
- You can access your report whichever country you are in without using
harddrive space
- Primary research throughout. You will not find this information anywhere
else
- Report stored in your reading room for ever
- Full searchable report when you buy the company or corporate editions
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables
View Cart
